SUNITA PANNACHAN: Open Payments
NPI 1518512383 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 11 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| Aurinia Pharma U.S., Inc. | 3 | $70 |
| SCPHARMACEUTICALS INC. | 2 | $38 |
| Ardelyx, Inc. | 1 | $34 |
| Novo Nordisk Inc | 1 | $34 |
| AKEBIA THERAPEUTICS INC | 1 | $28 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| Amgen Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
Products named: LUPKYNIS, FUROSCIX, IBSRELA, Vafseo, ACTHAR, KRYSTEXXA, MOUNJARO.
Industry payments across LA — which companies pay providers there.
